Market News & Trends
Biogen Renews License With Absorption Systems
Absorption Systems, a world leader in novel test systems for drug transporters, recently announced the renewal of a technology licensing deal with Biogen. After years…
Vetter: Choosing the Right Diluent to Help Maximize Success
Choose the Right Diluent to Help Maximize Success The biologics market continues to rise, expecting to reach $250 billion by 2024. Due to the unstable nature…
Healthcare Companies Must Embrace New Funding Sources as Venture Investment Continues to Decline
Although the life sciences industry remains an attractive investment area, the healthcare sector has seen a decline in venture investments, particularly for early stage investments,…
Tiziana Life Sciences Announces New Data With Foralumab, a Fully Human Anti-CD3 Antibody
Tiziana Life Sciences plc, the clinical-stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, recently announced new data from animal studies demonstrating the…
The Human Vaccines Project & Boehringer Ingelheim Partner to Accelerate the Development of Cancer Vaccines & Immunotherapies
The Human Vaccines Project and Boehringer Ingelheim are pleased to announce a 3-year collaboration agreement to support their mutual objective to decode the human immune…
Ropack Announces International Serialization Hub
Ropack Pharma Solutions recently announced it will launch an international serialization hub as a practical solution for pharmaceutical organizations and contract packaging partners that are…
Pharmaceutical Companies Lose $637 Billion in Revenue Annually
HealthPrize Technologies recently announced the publication of an update to a research paper co-authored with Capgemini estimating annual pharmaceutical revenue losses of $637 billion due…
PCI Clinical Services Announces Significant Expansion
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is extending its current Cryogenic storage capabilities to its Rockford, IL, operations, complementing the specialized capability…
Agilis Biotherapeutics Announces First Patient Treated in Phase IIb Clinical Study
Agilis Biotherapeutics recently announced that the first patient in the Phase IIb clinical study for its gene therapy treatment of Aromatic L-Amino Acid Decarboxylase (AADC)…
Ligand Partners Spectrum Pharmaceuticals & Lundbeck Receive FDA Approvals
Ligand Pharmaceuticals Incorporated recently announced that partner Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus…
Evonik Ramps Up Production Capacity for Biomaterials
Evonik is expanding its production facilities in Birmingham, AL, and Darmstadt, Germany. This will create additional capacity for the production of biodegradable polymers marketed globally…
MilliporeSigma Launches Next-Generation Technology for Advanced Live Cell Imaging
MilliporeSigma has launched the CellASIC® ONIX2 Microfluidic System for advanced live cell imaging. The system converts laboratory microscopes into powerful tools for live cell imaging…
Business Development Manager Needed at Fareva
Fareva is looking for a Business Development Manager/Director for the Northern American market, based in NJ, NYC, and CT, to manage its injectables/ophthalmics/high potent businesses.…
Cancer Vaccines Market Will Soar to $7.5 Billion by 2022
The cancer vaccines market is set to almost triple from $2.5 billion in 2015 to $7.5 billion by 2022, representing a strong compound annual growth…
Evonik Industries Submits Bid for Technology Platform
Amino acids produced by fermentation are an important pillar of Evonik’s product portfolio for sustainable animal nutrition. The production processes for Biolys (lysine), ThreAMINO (threonine),…
Caris Life Sciences Designates West Virginia University Cancer Institute a Center of Excellence
Caris Life Sciences recently announced the designation of the West Virginia University (WVU) Cancer Institute as a center of excellence site in the Caris Centers…
VWR International Acquires Reliable Biopharmaceutical Corporation & BioArra
VWR recently announced the acquisition of two companies, Reliable Biopharmaceutical and BioArra. Reliable Biopharmaceutical, a manufacturer of high-quality active pharmaceutical ingredients (APIs) and high-purity ingredients…
RedHill Biopharma Provides Update on Ongoing Phase II & III Studies
RedHill Biopharma Ltd. recently provided an update on its ongoing Phase III and Phase II clinical studies with BEKINDA for the treatment of acute gastroenteritis…
Mylan & BioCon Announce Regulatory Submission
Mylan N.V. and Biocon Ltd. recently announced that the European Medicines Agency (EMA) has accepted for review Mylan's Marketing Authorization Application (MAA) for insulin glargine,…
FDA Accepts Genentech’s Biologics License Application
Halozyme Therapeutics, Inc. recently announced that the US FDA has accepted Genentech's Biologics License Application for a subcutaneous formulation of rituximab in multiple blood cancer…
